Biliary excretion of rufloxacin in humans.

Rufloxacin is a new once-daily antibacterial fluoroquinolone with a long half-life. The aim of the present study was to evaluate the plasma and biliary kinetics and biliary and urinary excretion of rufloxacin in patients with extrahepatic cholestasis. Twelve patients with total external percutaneous...

Full description

Bibliographic Details

Published in:	Antimicrob Agents Chemother
Main Authors:	Privitera, G, Nicastro, G, Imbimbo, B P, Cesana, M, Visconti, M, Lombardi, F, Tagliabue, G, Faleschini, E, Colturani, F, Franzini, P
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 1993
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192734/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8109915/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.12.2545
Tags:	Add Tag No Tags, Be the first to tag this record!